rs35363062

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033641.4(COL4A6):​c.4082T>C​(p.Leu1361Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00539 in 1,193,027 control chromosomes in the GnomAD database, including 197 homozygotes. There are 1,639 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 99 hom., 796 hem., cov: 23)
Exomes 𝑓: 0.0030 ( 98 hom. 843 hem. )

Consequence

COL4A6
NM_033641.4 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.429

Publications

2 publications found
Variant links:
Genes affected
COL4A6 (HGNC:2208): (collagen type IV alpha 6 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
COL4A6 Gene-Disease associations (from GenCC):
  • hearing loss, X-linked 6
    Inheritance: XL Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, PanelApp Australia
  • X-linked nonsyndromic hearing loss
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • premature ovarian failure 1
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026853085).
BP6
Variant X-108163026-A-G is Benign according to our data. Variant chrX-108163026-A-G is described in ClinVar as Benign. ClinVar VariationId is 258278.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0953 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A6NM_033641.4 linkc.4082T>C p.Leu1361Pro missense_variant Exon 41 of 45 ENST00000334504.12 NP_378667.1 Q14031-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A6ENST00000334504.12 linkc.4082T>C p.Leu1361Pro missense_variant Exon 41 of 45 5 NM_033641.4 ENSP00000334733.7 Q14031-2

Frequencies

GnomAD3 genomes
AF:
0.0281
AC:
3126
AN:
111284
Hom.:
99
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0980
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00873
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00115
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000321
Gnomad OTH
AF:
0.0194
GnomAD2 exomes
AF:
0.00844
AC:
1369
AN:
162253
AF XY:
0.00459
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.00521
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000147
Gnomad OTH exome
AF:
0.00309
GnomAD4 exome
AF:
0.00304
AC:
3289
AN:
1081691
Hom.:
98
Cov.:
30
AF XY:
0.00240
AC XY:
843
AN XY:
351539
show subpopulations
African (AFR)
AF:
0.105
AC:
2650
AN:
25317
American (AMR)
AF:
0.00625
AC:
199
AN:
31856
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18828
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28835
South Asian (SAS)
AF:
0.000255
AC:
13
AN:
50884
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40370
Middle Eastern (MID)
AF:
0.00344
AC:
14
AN:
4064
European-Non Finnish (NFE)
AF:
0.000123
AC:
103
AN:
836071
Other (OTH)
AF:
0.00682
AC:
310
AN:
45466
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
117
234
351
468
585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0282
AC:
3138
AN:
111336
Hom.:
99
Cov.:
23
AF XY:
0.0237
AC XY:
796
AN XY:
33566
show subpopulations
African (AFR)
AF:
0.0982
AC:
2998
AN:
30529
American (AMR)
AF:
0.00872
AC:
92
AN:
10551
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2641
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3541
South Asian (SAS)
AF:
0.000766
AC:
2
AN:
2610
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6079
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.000321
AC:
17
AN:
52972
Other (OTH)
AF:
0.0192
AC:
29
AN:
1513
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
110
219
329
438
548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0108
Hom.:
518
Bravo
AF:
0.0335
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000346
AC:
1
ESP6500AA
AF:
0.105
AC:
403
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.00954
AC:
1158

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 23, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hearing loss, X-linked 6 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
6.0
DANN
Benign
0.32
DEOGEN2
Benign
0.24
.;T;.;.;T;T
FATHMM_MKL
Benign
0.0010
N
LIST_S2
Benign
0.46
T;T;T;T;T;T
MetaRNN
Benign
0.0027
T;T;T;T;T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
-1.4
.;N;.;.;.;.
PhyloP100
-0.43
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.68
N;N;.;N;.;.
REVEL
Benign
0.16
Sift
Benign
0.49
T;T;.;T;.;.
Sift4G
Benign
0.43
T;T;T;T;T;T
Polyphen
0.0040
B;B;.;B;.;.
Vest4
0.082
MVP
0.12
MPC
0.29
ClinPred
0.00056
T
GERP RS
1.4
Varity_R
0.059
gMVP
0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35363062; hg19: chrX-107406256; API